ASXC — Asensus Surgical Cashflow Statement
0.000.00%
Last trade - 00:00- $81.58m
- $89.11m
- $8.58m
Annual cashflow statement for Asensus Surgical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -154 | -59.3 | -62.5 | -75.6 | -78.4 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 76.8 | 11.2 | 6.24 | 10.2 | 8.42 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.35 | -10.7 | 1.23 | -4.96 | 2.52 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -73.5 | -46.7 | -40.7 | -58.9 | -63.6 |
| Capital Expenditures | -0.437 | -0.003 | -1.37 | -1.28 | -0.561 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 68.1 | 0 | -118 | 48.8 | 65.1 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 67.6 | -0.003 | -120 | 47.5 | 64.5 |
| Financing Cash Flow Items | -0.499 | -0.11 | -1.06 | -0.35 | -0.497 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5.61 | 53.4 | 162 | -0.332 | 9.63 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -11.1 | 6.96 | 1.75 | -11.8 | 11.3 |